QuidelOrtho

QuidelOrtho

QDEL· Manufacturing· Fiscal year ends in January

CEO pay in FY2025Stock -36.6% in FY2025

Brian J. Blaser is the CEO of QuidelOrtho and was paid $11.3M in FY2025 (Jan), down 25%.

Pay$100 in the stock at the end of FY23 → $51
CEO pay is from each QuidelOrtho proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Brian J. BlaserFY2025
  2. 2Joseph M. BuskyFY2025
  3. 3Michelle A. HodgesFY2025
  4. 4Philip D. McLellanFY2025
  5. 5Jonathan P. SiegristFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

QuidelOrtho paid its 5 named executives $23.9M in total in FY2025 (Jan). CEO Brian J. Blaser was paid $11.3M of that.

Name
Brian J. BlaserPresident and CEONot disclosed
Joseph M. BuskyCFO
Michelle A. HodgesFormer CLO
Philip D. McLellanCOONot disclosed
Jonathan P. SiegristEVP of R&D and CTONot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers19

See all

The FY2025 (Jan) proxy of QuidelOrtho names 19 peer companies for pay. Among QuidelOrtho and these peers, CEO pay was 3rd highest of 10 and total shareholder return was 9th highest of 10.

3rd highest of 10in QuidelOrtho and its pay peers, FY2025 (Jan) by CEO pay:

$4.7M$14.2M

9th highest of 10in QuidelOrtho and its pay peers, FY2025 (Jan) by total shareholder return:

$4$365

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board8

See all
  • Edward L. MichaelDirector · 7 yr on the boardIndependentCompensation (Chair), Science and Technology (Chair)—Paid as an executive
  • Ann D. RhoadsDirector · 5 yr on the boardIndependentAudit (Chair)—Paid as an executive
  • Joseph D. Wilkins Jr.Director · 4 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
  • Evelyn S. DilsaverDirector · 3 yr on the boardIndependentAudit—Paid as an executive
  • Brian J. BlaserDirector · 1 yr on the boardNot independent—Paid as an executive
  • John R. ChiminskiDirector · 1 yr on the boardIndependentAudit, Science and Technology—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    QuidelOrtho COO pay rose 25% to $2.0M. The stock fell 34% in FY2025 (Dec).
    DEF 14A
  2. Pay
    QuidelOrtho CFO pay rose 14% to $5.4M. The stock fell 34% in FY2025 (Dec).
    DEF 14A
  3. Pay
    QuidelOrtho CTO pay fell 34% to $1.8M. The stock fell 34% in FY2025 (Dec).
    DEF 14A
  4. Pay
    QuidelOrtho CEO pay fell 25% to $11.3M. The stock fell 34% in FY2025 (Dec).
    DEF 14A
  5. Pay
    QuidelOrtho COO pay rose 89% to $6.4M. The stock fell 40% in FY2024 (Dec).
    DEF 14A
  6. Pay
    QuidelOrtho COO pay rose 157% to $6.1M. The stock fell 17% in FY2022 (Jan).
    DEF 14A
  7. Pay
    QuidelOrtho General counsel pay rose 84% to $3.3M. The stock fell 40% in FY2024 (Dec).
    DEF 14A
  8. Pay
    QuidelOrtho General counsel pay fell 49% to $1.8M. The stock fell 14% in FY2023 (Dec).
    DEF 14A
  9. Pay
    QuidelOrtho General counsel pay rose 87% to $6.2M. The stock fell 40% in FY2024 (Dec).
    DEF 14A
  10. Pay
    QuidelOrtho CFO pay rose 60% to $4.7M. The stock fell 40% in FY2024 (Dec).
    DEF 14A
  11. Pay
    QuidelOrtho President pay rose 78% to $12.1M. The stock fell 40% in FY2024 (Dec).
    DEF 14A
  12. Pay
    QuidelOrtho President pay rose 136% to $12.9M. The stock fell 17% in FY2022 (Jan).
    DEF 14A
  13. Board
    R. Scott Huennekens joined the board of QuidelOrtho. R. Scott Huennekens sits on no other public board.
    3
  14. Board
    John R. Chiminski joined the board of QuidelOrtho. John R. Chiminski sits on no other public board.
    3
  15. Board
    Brian J. Blaser joined the board of QuidelOrtho. Brian J. Blaser sits on no other public board.
    3
  16. Pay
    QuidelOrtho SVP, Research and Development pay fell 35% to $2.0M. The stock fell 14% in FY2023 (Dec).
    DEF 14A
  17. Pay
    QuidelOrtho SVP, Research and Development pay rose 37% to $3.1M. The stock fell 17% in FY2022 (Jan).
    DEF 14A
  18. Pay
    QuidelOrtho COO pay fell 44% to $3.4M. The stock fell 14% in FY2023 (Dec).
    DEF 14A
  19. Pay
    QuidelOrtho President pay fell 48% to $6.8M. The stock fell 14% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 27, 2026FY2025
Annual report10-KFeb 19, 2026FY2025
Proxy statementDEF 14AApr 8, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 2, 2024FY2023
Annual report10-KFeb 29, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data